-
10 mM dNTP Mixture for DNA Workflows
2026-09-15
Build more consistent PCR, qPCR, sequencing, and DNA synthesis workflows with an equimolar nucleotide stock designed for straightforward dilution. The same reagent can also improve upstream DNA preparation and assay controls when studying how LNP charge and cellular state influence nucleic acid delivery.
-
MRT68921: ULK1 Kinase Inhibitor Workflows
2026-09-15
MRT68921 enables time-resolved inhibition of ULK1/2 to separate autophagy initiation from the broader energy-stress response. This workflow-centered guide combines ATG13 phosphorylation blockade, LC3 flux measurement, mutant controls, and AMPK-aware interpretation for more reproducible cellular assays.
-
Tetraethylammonium Chloride: Assay Workflows
2026-09-14
Tetraethylammonium chloride provides a practical perturbation tool for K+ channel pore studies, vascular assays, and carefully controlled β-cell experiments. This guide connects dual-site channel blockade with reproducible preparation, dose design, controls, and troubleshooting while distinguishing established evidence from workflow recommendations.
-
Prunin Targets the Senecavirus A IRES
2026-09-13
The reference study identifies prunin as an inhibitor of Senecavirus A replication and links its antiviral activity to reduced function of the viral internal ribosome entry site (IRES). Its combined in vitro, in vivo, and reporter-based strategy provides a useful framework for distinguishing general cytotoxicity from an effect on viral translation, while also highlighting the need for more detailed pharmacological and mechanistic validation.
-
Tioconazole Workflows for Antifungal Research
2026-09-12
Build reproducible Tioconazole assays for ergosterol-pathway studies, susceptibility testing, and fungal infection models with practical controls for solubility, dosing, and readout quality. The workflow also shows how the reference study’s metabolism–DNA repair findings can inform assay design without overextending evidence from leukemia research to fungal systems.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-09-12
A 2025 study developed a sensitive imaging platform to follow nucleic acid-loaded lipid nanoparticles through endocytic compartments. Its findings indicate that excess cholesterol promotes peripheral early-endosome trapping, while DSPC can reduce this aggregation, linking LNP composition to productive intracellular cargo trafficking.
-
T0070907: A Precision PPARγ Antagonist
2026-09-11
T0070907 enables controlled inhibition of human PPARγ for adipogenesis, transcriptional mechanism, macrophage inflammation, and cancer-cell studies. Its nanomolar potency and covalent receptor engagement make it especially useful for separating PPARγ-dependent effects from pathway-independent phenotypes.
-
HA Tag Peptide in Exosome Research
2026-09-11
A mechanistic and translational guide to using HA-tag workflows to interrogate RAB31-dependent exosome biology, with practical recommendations for competitive elution, controls, and evidence interpretation.
-
10 mM dNTP Mixture: Assay-Ready DNA Synthesis
2026-09-10
Explore how the 10 mM dNTP mixture supports reproducible PCR, sequencing, and DNA synthesis while providing a disciplined framework for interpreting nucleic acid delivery assays. This article connects nucleotide control with recent mechanistic evidence on lipid nanoparticle trafficking.
-
G007-LK Tankyrase 1/2 Inhibitor Workflow
2026-09-10
G007-LK combines nanomolar TNKS1/2 inhibition with practical readouts for Wnt/β-catenin and Hippo-pathway research. This workflow connects reporter assays, β-catenin degradation induction, colony formation, and YAP/AMOTL validation across APC mutation colorectal cancer research and hepatocellular carcinoma models.
-
Imatinib (STI571) Workflows for Kinase Research
2026-09-09
Imatinib (STI571) converts PDGFR, c-Kit, and Abl inhibition into practical assays for phosphorylation, proliferation, and pathway validation. This guide combines reproducible cell-based workflows with a reference-study framework for comparing PDGFR inhibition in cancer biology and pulmonary vascular models.
-
GSK2606414: PERK Inhibitor Assay Guide
2026-09-09
Learn how GSK2606414 (SKU A3448) can help distinguish PERK-dependent ER-stress signaling from nonspecific effects in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay design, dosing, solvent handling, interpretation, and practical product-selection criteria.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-09-08
The reference study developed tumor-microenvironment-responsive nanoparticles to deliver PTEN mRNA systemically and restore pathway control in trastuzumab-resistant HER2-positive breast cancer models. Its main contribution is to connect conditional nanoparticle exposure, transient tumor-suppressor expression, and PI3K/Akt signaling pathway inhibition in a single resistance-reversal strategy.
-
BFH772 (VEGFR2 inhibitor) Workflow Guide
2026-09-07
BFH772 is a selective VEGFR2 inhibitor for experiments that require controlled suppression of VEGFR2-associated signaling and angiogenesis-related readouts. Its organic-solvent compatibility supports concentrated stock preparation, but its water insolubility and limited published evidence make it unsuitable for unvalidated aqueous dosing, broad kinase profiling, or direct translation of animal findings into a treatment protocol.
-
Aprotinin in Protease-Controlled RNA Workflows
2026-09-07
Explore how Aprotinin, or bovine pancreatic trypsin inhibitor, can be evaluated as a defined protease-control reagent alongside nascent RNA workflows. This guide connects fibrinolysis inhibition and serine protease biology with the practical assay innovations of an affordable GRO-seq protocol.